Management of Small Renal Masses

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Surgical excision of renal cell carcinoma is the current standard of care for localized disease. Series for small renal masses treated with surgery demonstrate excellent oncologic outcomes with 5-year survival rates over 95%. Minimally invasive ablative technologies, such as cryotherapy and radiofrequency ablation, have recently emerged with similar short- and intermediate-term results. Additionally, recent data on active surveillance have demonstrated survival rates comparable to surgery and ablation in selected patient populations. We review the currently available data regarding the management of small renal masses by excision, ablation, or observation.

Original languageEnglish
Pages (from-to)352-358
Number of pages7
JournalSeminars in Ultrasound, CT and MRI
Volume30
Issue number4
DOIs
StatePublished - Aug 2009

Fingerprint

Dive into the research topics of 'Management of Small Renal Masses'. Together they form a unique fingerprint.

Cite this